cartilag regener requir balanc anabol catabol process examin suscept fibromodulin fmod lumican lum degrad mmp13 adamts4 adamts5 three major degrad proteinas articular cartilag cartilag develop osteoarthr immunoloc fmod lum fetal foot adult knee cartilag use fmod matrix metalloproteas mmp13 neoepitop antibodi tsyg11 ctermin antifmod pr184 antilum pr353 antibodi vitro digest knee cartilag mmp13 disintegrin metalloproteas thrompospondin motif adamts4 adamts5 assess whether fmod lum fragment observ western blot total knee replac specimen could gener normal ovin articular cartilag explant cultur interleukin il1 oncostatinm osm pge3162689 broad spectrum mmp inhibitor assess fmod lum collagen degrad fmod lum immunoloc metatars phalang fetal rudiment cartilag growth plate antibodi tsyg11 local mmp13cleav fmod hypertroph chondrocyt metatars growth plate fmod promin local superfici cartilag normal fibril zone cartilag tsyg11posit fmod locat deep cartilag sampl tsyg11 identifi fmod fragment western blot normal fibril cartilag extract total knee replac cartilag ctermin antifmod pr184 fail identifi fmod fragment due ctermin process ctermin lum pr353 identifi three lum fragment cartilag vitro digest human knee cartilag mmp13 adamts4 adamts5 gener fmod fragment kda similar blot cartilag lum less suscept fragment pr353 detect ntermin process lum fragment kda 6580yearold knee replac cartilag fmod lum differenti process mmp13 adamts4 adamts5 digest fmod suscept degrad mmp13 adamts4 lesser extent adamts5 howev lum mmp13cleav fmod metatars phalang fetal rudiment growth plate cartilag suggest role skeletogenesi pathogenesi explant cultur ovin cartilag stimul il1osm pge3162689 display gag loss day due adamt activ howev day activ prommp occur well degrad fmod collagen chang inhibit pge3162689 partli explain fmod fragment seen potenti therapeut util pge3162689 
matrix metalloproteinas mmp class zinc depend endopeptidas play crucial role multitud sever diseas cancer osteoarthr employ mmp13 target enzym structurebas design synthesi inhibitor abl recogn catalyt zinc ion addit alloster bind site order increas affin ligand guid molecular model optim initi alloster inhibitor addit linker fragment weak zinc binder recognit catalyt center furthermor improv lipophil ligand effici lle initi inhibitor appropri zinc bind fragment lower clogp valu inhibitor maintain potenc synthes inhibitor show elev affin compar initi hit also novel inhibitor display better lle deriv carboxyl acid zinc bind fragment turn potent inhibitor compound zhawoc5077 ic50 134 wherea acyl sulfonamid show best lipophil ligand effici compound zhawoc5135 lle 291 
sustain inflamm matrix metalloproteinas mmp activ contribut vascular occlusiveprolif disord interleukin17 il17 proinflammatori cytokin signal mainli via traf3 interact protein traf3ip2 upstream regul variou critic transcript factor includ ap1 nfb reversionxa0induc cysteinexa0rich protein kazal motif reck membraneanchor mmp inhibitor investig whether il17atraf3ip2 signal promot mmp13depend human aortic smooth muscl cell smc prolifer migrat determin whether reck overexpress blunt respons inde il17a treatment induc jnk p38 mapk ap1 nfb creb activ mir21 induct mir27b mir320 inhibit mmp13 express activ reck suppress smc migrat prolifer traf3ip2depend manner fact gain trag3ip2 function induc mmp13 express activ reck suppress furthermor treatment recombin mmp13 stimul smc migrat part via erk activ importantli reck gainoffunct attenu mmp13 activ without affect mrna protein level inhibit il17a mmp13induc smc migrat result indic increas mmp13 decreas reck contribut il17ainduc traf3ip2depend smc migrat prolifer suggest traf3ip2 inhibitor reck induc potenti block progress neointim thicken hyperplast vascular diseas 
complic diabet neuropathi condit sensori axon degener origin epidermi mechan remain unknown reactiv oxygen speci implic thi condit thi studi assess role candid downstream target mmp13 glucoseinduc sensori axon degener zebrafish mice effect glucos metabol sensori axon degener assess use qpcr live imag analyz use pentafluorobenzenesulfonyl fluorescein activ nfb stress respons determin use tgnfbgfp zebrafish role mmp13 glucosedepend axon degener determin zebrafish follow treatment antioxid nacetylcystein mmp13 inhibitor db04760 neuropath mice fed highfathighsugar diet treat mmp13 inhibitor cl82198 assess sensori recoveri glucos treatment zebrafish induc metabol chang resembl diabet sensori axon degener mediat rosinduc mmp13 prevent upon antioxid treatment mmp13 inhibit mmp13 inhibit also revers neuropathi diabet mice demonstr zebrafish suitabl studi glucoseinduc neurotox given effect zebrafish mice mmp13 inhibit may benefici treatment human diabet neuropathi 
adam8 report promot extracellular matrix degrad provid condit tumor metastasi howev underli mechan adam8 modul chondrosarcoma metastasi remain unclear use two human cell line sw1353 hcs28 analyz express profil adam8 cell compar normal chondrocyt import proteolyt enzym mmp13 detect marker extracellular matrix degrad chondrocyt silenc overexpress adam8 effect cell migrat invas sw1353 hcs28 downstream signal transduct pathway evalu adam8 mmp13 highli express nfb pathway activ sw1353 hcs28 cell silenc adam8 significantli reduc abil cell migrat invas block nfb signal pathway p65 dephosphoryl lead reduc nfb transcript activ decreas mmp13 express adam8 overexpress promot process howev revers inhibitor bay 117085 data show novel regul mechan adam8 promot migrat invas activ nfbmmp13 signal axi modul level may serv potenti target treatment even cartilag diseas 
patholog progress osteoarthr involv degrad articular cartilag matrix type collagen main compon cartilag matrix degrad proinflammatori cytokin il1 mediat mmp13 nebivolol licens drug use treatment hypertens clinic display antiinflammatori capac variou condit howev whether nebivolol protect effect cartilag matrix degrad report befor thi studi investig effect nebivolol regul express mmp13 degrad type collagen result indic nebivolol allevi increas gene express protein express activ mmp13 induc il1 importantli il1 strikingli reduc level type collagen cell cultur supernat revers treatment nebivolol dosedepend manner mechanist nebivolol found allevi increas level phosphoryl reduc level total induc il1 subsequ mitig p65 nuclear transloc transcript activ nfb furthermor result indic il1 treatment result signific increas express transcript factor interferon regulatori factor1 irf1 mrna protein level significantli amelior treatment nebivolol combin find suggest nebivolol potenti appli human treatment 
matrix metalloproteinas mmp inhibitor play role pathobiolog retin detach prolif vitreoretinopathi pvr prolif vitreoretinopathi facilit chronic retin detach involv excess deposit extracellular matrix ecm protein matrix metalloproteinase2 import modul ecm evalu purpos thi studi investig retin express select mmp includ mmp12 mmp13 associ inhibitor murin model retin detach transient chronic retin detach induc subretin inject either salin hyaluron acid c57bl6 mice confirm hard model featur consist pvrlike chang glial activ subretin fibrosi evalu immunofluoresc dilat fundu examin spectraldomain optic coher tomographi sdoct gene express quantifi qrtpcr protein assay immunoblot immunohistochemistri hyaluron acid eye develop gliosi subretin fibrosi dilat exam sdoct immunofluoresc analysi gene express mmp12 mmp13 timp1 strongli upregul time point compar control timp2 mmp2 mmp9 express modest hyaluron acid exhibit mmp timp express sard mmp12 timp1 protein elev compar control immunohistochemistri reveal moder strong mmp13 level subretin space macrophag fibrosi develop hard model upregul select mmp may modul wound heal process follow 
matrix metalloproteinase13 mmp13 attract drug target treatment osteoarthr thi studi seri quinazolinon deriv mmp13 inhibitor firstli systemat studi use qsar molecular dock molecular dynam simul reliabl comfa iqisup2sup 0646 irisup2sup 0992 irisubpredsubsup2sup 0829 comsia iqisup2sup 0704 irisup2sup 0992 irisubpredsubsup2sup 0839 model construct verifi topom comfa model result contour map indic electrostat hydrophob hbond acceptor field primarili influenc activ mmp13 inhibitor model sever key residu ala238 thr245 thr247 met253 asn215 lys140 identifi import factor improv activ stabil inhibitor hydrogen bond electrostat interact base result eight novel quinazolinon bd1d8b design addit design compound show good pharmacokinet properti admet predict compound bd3b bd8b exhibit excel predict activ simul analysi reveal hydrogen bond interact residu ser250 gly248 enhanc small group ushap conform pivot import result provid strong guidanc discoveri design novel potenti mmp13 inhibitor 
matrix metalloproteinas like mmp13 cleav remodel extracellular matrix therebi play crucial role tumor progress vivo use highli select inhibitor block mmp13 protein activ demonstr strike inhibitori effect invas tumor growth vascular murin skin squamou cell carcinoma scc therapi outcom critic depend anim age c57bl6 mice success old femal young femal mice treatment success recov ovariectomi young abolish 17estradiol supplement old mice suggest hormon depend inhibitor effect respons tumorigen keratinocyt bdvii fibroblast 17estradiol confirm vitro mmp13 inhibitor treatment led reduct cell invas vascular endotheli growth factor vegf releas thi correl well less invas vascular tumor treat mice vivo 17estradiol supplement also reduc invas vegf releas vitro addit reduct mmp13 inhibitor treatment thi suggest low 17estradiol level old mice vivo lead enhanc mmp13 level vegf releas allow effect inhibitor treatment compar young mice studi present strong link lower estrogen level old femal mice elev mmp13 level result effect mmp13 inhibitor treatment fibroblast scc cell vitro vivo 
adipos tissu remodel matrix metalloproteas mmp critic tissu hypertrophi obes mmp13 import protein highli express adipos tissu whose potenti role adipos tissu expans poorli character investig effect pharmacolog inhibit mmp13 select inhibitor cp544439 adipos tissu mass mice high fat diet determin effect inhibitor dure vitro adipocyt differenti 3t3l1 cell cp544439 administ week mice high fat diet bodi adipos glucos toler determin differenti 3t3l1 adipocyt also treat inhibitor maximum day adipogenesi assess treatment mice inhibitor result reduct bodi adipos improv glucos clearanc histolog examin epididym adipos show reduc adipocyt hypertrophi accompani increas stain collagen inhibitor treat mice treatment differenti 3t3l1 cell inhibitor result reduc adipocyt differenti knockdown mmp13 use small interf rna differenti 3t3l1 cell reduc adipocyt differenti indic reduc express ppar result suggest mmp13 may play major role adipos develop inhibit could potenti strategi prevent obes 
despit recent improv therapi osteosarcoma 3040 osteosarcoma patient die thi diseas mainli due lung metastasi previous report intraven inject mir143 significantli suppress lung metastasi human osteosarcoma cell 143b mous model thi studi examin biolog role mechan mir143 metastasi human osteosarcoma cell identifi plasminogen activ inhibitor1 pai1 direct target gene mir143 determin role pai1 human osteosarcoma cell sirna transfect 143b cell knockdown pai1 express vitro studi show downregul pai1 suppress cell invas activ prolifer moreov inject pai1 sirna primari lesion osteosarcoma mous model inhibit lung metastasi compar control sirnainject mice without influenc prolif activ tumor cell subsequ examin use 143b cell reveal knockdown pai1 express result downregul express secret matrix metalloproteinase13 mmp13 also target gene mir143 proteolyt enzym regul tumorinduc osteolysi immunohistochem analysi use clinic sampl show higher mir143 express case show poor express pai1 primari tumor cell case belong lung metastasisneg group moreov frequenc lung metastasisposit case significantli higher pai1 mmp13 doubleposit case pai1 mmp13 singleposit doubleneg case pxa0xa0005 result indic pai1 target gene mir143 regul invas lung metastasi via enhanc mmp13 express secret human osteosarcoma cell suggest molecul could potenti therapeut target gene prevent lung metastasi osteosarcoma patient 
regul activ normal express secret rantescc ligand ccl5 particip rheumatoid arthriti pathogenesi facilit leukocyt infiltr howev patholog function fulli defin present studi evalu effect rantesccl5 tissu degrad enzym matrix metalloproteinase1 mmp1 mmp13 express contribut progress joint damag synovi fibroblast rasf result show rantesccl5 dose depend induc mmp1 mmp13 express monolay threedimension micromass human rasf correl increas collagenas activ thi activ rantesccl5 observ rasf osteoarthr oasf evalu signal event show rantesccl5 select activ pkc jnk erk protein induc mmp express human rasf pretreat function antagonist metrant heparinas iii enzym select digest heparan sulfat proteoglycan hspg complet abrog rantesccl5induc mmp1 mmp13 express interestingli inhibit rantesccl5 use smallinterf rna approach reduc abil interleukin1 il1 induc mmp1 mmp13 express assert mediatori role tissu remodel inhibitor studi onli select inhibit hspg pkc erk jnk markedli inhibit rantesccl5induc mmp1 mmp13 product circular dichroism spectroscopi result demonstr degrad collagen triplehel structur upon exposur condit media rantesccl5 stimul rasf revert broadspectrum mmp inhibitor gm6001 find suggest rantesccl5 onli upregul mmp1 mmp13 express partli util hspg andor pkcjnkerk pathway also mediat il1induc mmp1 mmp13 express 
matrix metalloproteinas mmp13 play import role process proinflammatori cytokineinduc intervertebr disc degener idd thi studi examin effect il17 regul mmp13 extracellular matrix ecm intervertebr disc ivd examin whether salubrin known inhibitor eif2 dephosphoryl inhibit il17induc chang mention abov furthermor demonstr potenti therapeut role salubrin allevi chronic inflammatorydepend degen state commonli observ idd inflammatori distress il17 rtpcr western blot employ investig express mmp13 collagen type col2a1 collagen type col1a1 aggrecan acan nucleu pulpou tissu activ nfkb pathway measur western blot immunocytochemistri follow il17 treatment also examin level eif2 phosphoryl il17 treatment without salubrin investig interact nfkb pathway eif2 phosphoryl moreov employ salubrin specif inhibitor nfkb bay117082 evalu effect il17driven regul mmp13 ecm well activ nfkb result show il17 increas product mmp13 decreas express col2a1 acan via nfkb pathway either il17 salubrin increas level eif2 phosphoryl effect bay117082 level peif2 detect bay117082 salubrin significantli suppress il17driven intervertebr disc degener furthermor salubrin produc stronger effect bay117082 result impli potenti involv il17 idd activ nfkb signal success upregul express mmp13 led degrad ecm furthermor salubrin inhibit thi process inhibit nfkb activ directli link eif2 phosphoryl suggest potenti therapeut role idd 
p2x purinoceptorxa07xa0p2x7 receptorxa0p2x7r known play signific role inflamm paincaus diseas includ osteoarthritisxa0oa howev mechan action p2x7r role remain unclear articular cartilag crucial region patholog chang occur involv dysregul degrad mainten mechan thi studi aim reveal molecular mechan action p2x7r articular cartilag oainduc pain inflamm use azd9056 antagonist p2x7r creat anim model use wistar rat administeredxa0bi intraarticular inject monosodium iodoacetatexa0mia rat treat p2x7r antagonist azd9056 found treatment azd9056 exert painreliev antiinflammatori effect importantli found upregul express interleukinxa0il1 il6 tumor necrosi factorxa0tnf matrix metalloproteinase13xa0mmp13 substancexa0pxa0sp prostaglandinxa0e2xa0pge2 induc mia cartilag tissu revers azd9056 western blot analysi use examin express inhibitor nuclear factorbxa0nfb kinasexa0ikk ikk inhibitor nfbxa0ib nfbxa0p65 phosphoryl form found significantli increas knee cartilag tissu rat howev opposit effect observ inject azd9056 result impli p2x7r associ activ nfb pathway develop result also reveal helenalin nfb pathway inhibitor decreas express p2x7r il1 il6 tnf pge2 mmp13 induc mia knee cartilag tissu rat whole find suggest p2x7r regul mmp13 nfb pathway cartilag tissu mediat oainduc pain inflamm 
thi studi aim explor whether estradiol protect effect intervertebr disc degener ivdd rat model forti threemonthold femal spragu dawley rat randomli divid four group sham ovariectomi ovx ici182780 ici sham group onli underw resect bit fat ovx group underw bilater ovariectomi group treat base ovx ici group treat pretreat ici182780 inhibitor estrogen receptor base ovx radiographi hematoxylin eosin stain immunohistochemistri ihc western blot quantit realtim pcr qrtpcr appli detect apoptosi characterist intervertebr disc cell radiograph show mark intervertebr disc narrow stain show typic apoptosi characterist intervertebr disc cell ovx revers furthermor result ihc western blot qrtpcr reveal ovxinduc ivdd protect decreas express caspase3 intracellular matrix metalloproteinas mmp includ mmp3 mmp13 increas express collagen type detect effect abolish treatment ici182780 17e2 inhibit ivdd downregul mmp3 mmp13 upregul collagen type rat model 
matrix metalloproteinase13 mmp13 member collagenas famili enzym implic play key role patholog osteoarthr recent report discoveri seri quinazoline2carboxamid base nonzincbind mmp13 select inhibitor exemplifi compound continu research novel class zincbind inhibitor obtain followup compound differ physicochem pharmacokinet biolog activ profil order design select mmp13 inhibitor adopt strategi connect zincbind group quinazoline2carboxamid system uniqu binder appropri linker among synthes compound triazolon inhibitor exhibit excel potenc icsub50sub0071nm select greater 170fold mmp mmp1 tumor necrosi factor convert enzym tace thi articl design synthesi biolog activ novel zincbind mmp13 inhibitor describ 
investig serum saliva concentr matrix metalloproteinas mmp8 mmp9 mmp13 tissu inhibitor timp1 group patient without periodont sweden hypothesi biomark higher periodont patient nineti patient particip thi crosssect studi fiftyon patient periodont wherea periodont healthi saliva serum sampl analyz immunofluorometr enzymelink immunosorb assay western blot result statist analyz independ test mannwhitney test bonferroni correct regress analys mmp13 detect serum saliva higher valu found among periodont healthi compar periodont subject 032xa0xa0026 021xa0xa0023xa0ngml pxa0xa005 femal gender clinic attach loss explanatori factor higher salivari mmp13 valu odd ratio 308 confid interv 117 811 357 confid interv 108 1182 respect statist signific differ group found serum saliva valu mmp8 mmp9 timp1 contrari hypothesi statist signific differ patient without periodont seen mmp8 mmp9 timp1 valu howev higher mmp13 concentr saliva associ femal gender higher clinic attach loss metabol mmp13 may thu gender implic periodont 
previou studi 17estradiol prove protect rat annulu fibrosu cell apoptosi induc interleukin1 il1 howev whether 17estradiol protect effect rat nucleu pulposu cell remain unclear purpos thi studi explor effect 17estradiol rat nucleu pulposu cell base il1induc apoptosi tunel assay annexin vpi doubl stain use detect apoptosi reveal il1 induc notabl apoptosi revers 17estradiol meanwhil cell viabil bind abil decreas il1 activ caspase3 increas howev detect effect il1 elimin 17estradiol furthermor realtim quantit rtpcr use find il1 downregul express level type collagen aggrecan tissu inhibitor matrix metalloproteinas timp1 upregul matrix metalloproteinas mmp3 mmp13 bcl2 confirm western blot final 17estradiol prove abolish abov neg effect il1 summari thi work present il1 mayb induc apoptosi rat nucleu pulposu cell resist 17estradiol downregul mmp3 mmp13 via mitochondri pathway thi research provid novel insight antiapoptot effect 17estradiol il1induc cytotox may potenti lead better understand clinic effect 17estradiol especi term intervertebr disc degener 
matrix metalloproteinas mmp13 degrad collagen extracellular matrix aberr activ associ diseas arthriti cancer atherosclerosi fibrosi wide rang mmp13 proteolyt capac suggest power potenti destruct proteinas thu believ mmp13 produc adult human tissu steadi state present studi reveal human chondrocyt isol healthi adult constitut express secret mmp13 rapidli endocytos degrad chondrocyt pro activ mmp13 bind cluster iii lowdens lipoprotein ldl receptorrel protein lrp1 domain delet studi indic hemopexin domain respons thi interact bind competit mmp13 adamts4 timp3 also bind cluster shown mmp13 bind site within cluster differ adamts4 timp3 mmp13 therefor coendocytos adamts5 timp3 human chondrocyt find indic mmp13 may play role physiolog turnov cartilag extracellular matrix lrp1 key modul extracellular level mmp13 intern independ level adamts4 timp3 
osteoarthr nonsystem diseas oral parenter diseasemodifi osteoarthrit drug dmoad current avail matrix metalloproteinas mmp13 attract attent target diseasemodifi potenti becaus major role tissu destruct associ local one joint amen intraarticular therapi distinct advantag oral therapi term increas therapeut index maxim drug deliveri cartilag minim system exposur report synthesi biolog evalu nonzinc bind mmp13 select inhibitor 4methyl1s53oxo34dihydro2hbenzo14oxazin6ylmethylcarbamoylpyrazolo15apyrimidine7carbonylaminoindan5carboxyl acid uniqu suit potenti iadmoad long durabl joint penetr cartilag effect exhibit nearli detect system exposur remark efficaci 
estrogen defici close relat develop menopaus arthriti estrogen replac therapi ert show protect effect osteoarthr howev underli mechan thi protect effect unknown thi studi aim determin role mir140 estrogendepend regul mmp13 human chondrocyt primari human articular chondrocyt obtain femal patient undergo knee replac surgeri normal articular chondrocyt isol knee joint femal donor trauma treat interleukin1 beta il1 gene express level mir140 mmp13 adamts5 detect quantit realtim pcr qrtpcr mir140 level upregul downregul transfect cell mirna mimic inhibitor respect prior treatment il1 mmp13 express evalu western blot immunofluoresc luciferas report assay perform verifi interact mir140 17estradiol suppress mmp13 express human articular chondrocyt mir140 express upregul estrogen treatment knockdown mir140 express abolish inhibitori effect estrogen mmp13 addit estrogenermir140 pathway show inhibitori effect il1induc cartilag matrix degrad thi studi suggest estrogen act via mir140 inhibit catabol activ proteas within chondrocyt extracellular matrix find provid new insight mechan menopaus arthriti indic ermir140 signal pathway may potenti target therapeut intervent menopaus arthriti 
age one promin risk factor patholog progress osteoarthr one featur agerel chang advanc glycat end product age accumul articular cartilag autophagi play cellular housekeep role remov dysfunct cellular organel protein howev relationship autophagi ageassoci unknown aim thi studi determin whether autophagi particip patholog agetr chondrocyt investig exact role autophagi ageinduc cell apoptosi express matrix metalloproteinas mmp mmp13 age induc notabl apoptosi detect annexin vpi doublestain upregul mmp3 mmp13 confirm western blot autophagyrel protein also determin western blot chondrocyt transfect mcherrygfplc3badenoviru monitor autophag flux result autophagi significantli increas chondrocyt peak 6u2009h furthermor rapamycin attenu ageinduc apoptosi express mmp3 mmp13 autophagi activ contrast pretreat autophagi inhibitor 3methyladenin 3ma enhanc abovement effect age therefor demonstr autophagi link agerel patholog rat chondrocyt play protect role ageinduc apoptosi express mmp3 mmp13 
basi superposit studi xray crystal structur complex quinazolin deriv triazol deriv matrix metalloproteinas mmp13 catalyt domain novel seri fuse pyrimidin compound possess 124triazol3yl group zinc bind group zbg design among herein describ evalu compound 31f exhibit excel potenc mmp13 icsub50sub 0036 select greater 1500fold mmp mmp1 tumor necrosi factor convert enzym tace furthermor inhibitor shown protect bovin nasal cartilag explant degrad induc interleukin1 oncostatin thi articl report discoveri extrem potent highli select oral bioavail fuse pyrimidin deriv possess 124triazol3yl group novel zbg select mmp13 inhibit 
studi effect low intens puls ultrasound lipu express tissu inhibitor metalloproteinase2 timp2 serum express matrix metallopeptidas mmp13 articular cartilag cell rabbit knee osteoarthr inner patellar ligament defect method use establish model knee four week model arteri blood drawn ear rabbit elisa employ detect express timp2 serum chondrocyt separ anim group cultur inxa0vitro rabbit divid control group model group oaxa0xa0lipu group cell control group treat cell oaxa0xa0lipu group treat lipu 40xa0mwcm2 timeday cell collect 7xa0d later rna total protein extract respect realtim pcr western blot employ analyz express mmp13 chondrocyt mrna protein level respect success rate establish model result elisa show content timp2 serum anim 223 lower one control group pxa0xa0005 compar normal control group express timp2 model group significantli increas express mmp13 significantli increas pxa0xa0005 stimul lipu express timp2 mmp13 close one normal control group inner patellar ligament defect method matur method establish rabbit model high success rate express serum timp2 model group significantli decreas lipu upregul timp2 downregul mmp13 
evalu decreas cartilag destruct novel oral activ specif matrix metalloproteinas mmp13 inhibitor three differ anim model rheumatoid arthriti scid mous coimplant model collageninduc arthriti cia model mice antigeninduc arthriti model aia rabbit use scid mous coimplant model mmp13 inhibitor reduc cartilag destruct cia model mmp13 inhibitor result signific dosedepend decreas clinic symptom well cartilag eros mgkg mgkg mgkg signific effect seen aia model toxic effect seen three anim model although sever mmp concert proteinas role process cartilag destruct need highli select mmp inhibitor reduc sever side effect occur nonspecif inhibitor signific inhibit mmp13 reduc cartilag eros two three test anim model result strongli support develop thi class drug reduc halt joint destruct patient 
age one major patholog factor associ osteoarthr recent numer report demonstr impact sirtuin1 sirt1 naddepend deacetylas human age demonstr sirt1 induc osteogen chondrogen differenti mesenchym stem cell howev role sirt1 chondrocyt still remain unknown postul sirt1 regul hypertroph chondrocyt lineag degener articular cartilag activ osteogen transcript activ runx2 matrix metalloproteinas mmp13 chondrocyt verifi whether sirtuin1 sirt1 regul chondrocyt activ studi express sirt1 runx2 product mmp13 associ human chondrocyt express sirt1 ubiquit observ osteoarthrit chondrocyt contrast runx2 express osteophyt region patient model mice relat catabol factor il1increas express runx2 chondrocyt chondrocyt pretreat sirt1 inhibitor inhibit il1induc express runx2 compar control sinc runx2 promotor mmp13 express sirt1 inactiv may inhibit runx2 express result downregul mmp13 product chondrocyt find suggest thatsirt1 may regul express runx2 osteogen transcript factor product mmp13 chondrocyt sinc sirt1 activ known affect sever stress includ inflamm oxid stress well age sirt may involv develop 
even though increas evid mirna involv human patholog respons distinct role relat mechan mirna patholog osteoarthr yet fulli understood rna level protein level apoptot gene hdac mmp13 mirna human chondrocyt isol normal biopsi sampl cartilag analyz realtim pcr western blot exogen modul mir222 level perform use deliveri specif precursor specif inhibitor target valid assay appli identifi potent target vivo studi use dmm mice model perform assess degre cartilag degrad accord mirna profil mir222 significantli downregul chondrocyt overexpress mir222 significantli suppress apoptot death downregul hdac4 mmp13 level moreov 3utr report assay show hdac4 direct target mir222 treatment chondrocyt hdac inhibitor trichostatin tsa suppress mmp13 protein level apoptosi wherea overexpress hdac4 display opposit effect introduct mir222 cartilag medial meniscu destabil mice significantli reduc cartilag destruct mmp13 level taken togeth data suggest mir222 may involv cartilag destruct target hdac4 regul mmp13 level 
although sever matrix metalloproteinas mmp implic testi develop presenc mmp13 protein directli substanti male avian gonad thi studi examin express pattern mmp13 mmp inhibitor timp1 timp2 immatur 4week prepubert 16week matur 1year chicken test use rtpcr analysi observ mmp13 mrna express immatur testi western blot analysi express level mmp13 protein peak immatur test dure mark tissu remodel wherea gradual decreas dure testi matur high express level timp1 34kda timp2 55kda detect onli immatur prepubert test adult testi four differ form timp2 protein differenti detect test grow adult chicken use immunohistochemistri local secret intracellular form mmp13 timp1 timp2 protein protein tempor spatial distribut grow adult test express level similar express profil western blot result find suggest agerel chang mmp13 balanc timp act concert effect control testicular remodel matur 
osteoarthr chronic joint diseas character progress loss articular cartilag dure proinflammatori cytokin interleukin il1 induc express matrix metalloproteinas mmp chondrocyt contribut thu extracellular matrix ecm degrad member serpin famili includ plasminogen activ inhibitor report particip ecm regul aim thi studi assess express serpin peptidas inhibitor clade member serpine2 basal condit respons increas dose il1 human cultur chondrocyt also examin effect serpine2 il1induc mmp13 express complet signal pathway involv thi process also explor serpine2 mrna protein express evalu rtqpcr western blot analysi human tc28a2 cell line human primari chondrocyt cell treat human recombin serpine2 alon combin il1 erk nfb ap1 activ assess western blot analysi human cultur chondrocyt express serpine2 basal condit thi express increas respons il1 stimul addit recombin serpine2 induc clear inhibit mmp13 express il1stimul chondrocyt thi inhibitori effect like regul pathway involv erk nfb ap1 taken togeth data demonstr serpine2 might prevent cartilag catabol inhibit express mmp13 one relev collagenas involv cartilag breakdown 
studi effect hydrogen sulfid left ventricular express mmp8 mmp13 timp1 rat model congenit heart diseas male rat underw abdomin aortainferior vena cava shunt oper donor nah molkg1d1 inject next day week week hemodynam paramet includ left ventricular systol pressur lvsp left ventricular peak rate contract relax dpdtmax left ventricular end diastol pressur lvedp measur left ventricular tissu dissect hydroxyprolin collagen content detect elisa express mmp8 mmp13 tissu inhibitor metalloproteinase1 timp1 tissu measur use realtim pcr western blot immunohistochemistri respect shunt oper markedli reduc lvsp dpdtmax increas lvedp hydroxyprolin collagen content well mrna protein level mmp8 mmp13 timp1 left ventricl chronic treatment shunt oper rat nah effect prevent abnorm hemodynam paramet hydroxyprolin collagen content mrna protein level mmp13 timp1 left ventricl nah also prevent increas mmp8 protein express affect increas mrna level mmp8 shunt oper rat suppress protein mrna express mmp8 mmp13 timp1 rat cardiac volum overload may contribut amelior ventricular structur remodel cardiac function 
